Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ResVir Novel Technologies for Respiratory Virus Identification

NCT05661032 is registered in ClinicalTrials.gov with Portsmouth Hospitals NHS Trust as lead sponsor.

NCT NCT05661032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05661032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ResVir Novel Technologies for Respiratory Virus Identification
Lead sponsor
Portsmouth Hospitals NHS Trust
Phase
Observational
Overall status
Recruiting
Start date
January 18, 2023
Completion date
June 30, 2027
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infections, respiratory, respiratory tract infections